Tue, 01/21/2025 - 13:53 |
Cannabinoids offer new hope for safe and effective pain relief |
YaleUniversity |
Thu, 01/16/2025 - 18:25 |
Study: Orally Administered CBD Significantly Reduces Pain, Other Symptoms in Patients with Nail-Patella Syndrome |
NORML |
Wed, 01/15/2025 - 23:27 |
IASP Announces the Theme for the 2025 Global Year: Pain Management, Research, and Education in Low- and Middle-Income Settings |
International A... |
Sat, 01/11/2025 - 07:37 |
Global Pain Treatment Market to Reach $144.2 Billion by 2029 |
BCC Research |
Thu, 12/19/2024 - 21:50 |
Review: Clinical Trials Demonstrate Effectiveness of Cannabinoids for Managing Peripheral Neuropathy |
NORML |
Fri, 08/09/2024 - 16:45 |
New National Academies Report Calls for Better Research on Women's Health Issues |
American Physic... |
Mon, 07/15/2024 - 09:46 |
Boston Scientific Announces Clinical Data from Chronic Pain Portfolio at the 2024 American Society of Pain & Neuroscience Conference |
Boston Scientif... |
Mon, 07/15/2024 - 09:15 |
Five-year pooled results for Intracept Intraosseous Nerve Ablation System demonstrate significant pain and function improvements in patients with vertebrogenic low back pain |
Boston Scientific |
Wed, 07/10/2024 - 13:03 |
Boston Scientific to Present Key Data at the 2024 American Society of Pain & Neuroscience Conference |
Boston Scientific |
Wed, 06/19/2024 - 10:45 |
Data From Lexicons RELIEF-DPN 1 Phase 2 Study of LX9211 Published Today in Diabetes Care, a Peer-Reviewed Journal of the American Diabetes Association |
Lexicon Pharmac... |
Fri, 03/01/2024 - 19:23 |
Four things to know about our acquisition of Relievant Medsystems |
Boston Scientif... |
Mon, 02/26/2024 - 17:09 |
AANA Applauds Addition of CRNAs To SAMHSA Practitioner List |
AANA |
Tue, 02/06/2024 - 20:55 |
Supported by the positive one-year SOLIS randomized control trial results |
Boston Scientific |
Tue, 02/06/2024 - 09:36 |
FDA Approves Boston Scientific Spinal Cord Stimulator Systems for Treatment of Non-Surgical Back Pain |
Boston Scientif... |
Wed, 11/02/2022 - 07:12 |
IASP Announces 2022 Early Career Research Grant Recipients |
International A... |
Mon, 10/24/2022 - 14:09 |
Lexicon Pharmaceuticals Announces Oral Presentations Relating to Its LX9211 Neuropathic Pain Program at the World Brain Disorders and Neuroscience Summit 2022 |
Lexicon Pharmac... |
Mon, 10/24/2022 - 00:31 |
American Society of Anesthesiologists recognizes Vivianne Tawfik, M.D., Ph.D., with its 2022 James E. Cottrell Presidential Scholar Award |
American Societ... |
Fri, 09/09/2022 - 18:28 |
Karen Little, NP, is a chronic pain nurse practitioner at the |
Massachusetts G... |
Thu, 08/11/2022 - 07:39 |
Study finds that sound plus electrical body stimulation has potential to treat chronic pain |
UniversityofMin... |
Wed, 04/06/2022 - 08:44 |
Biomarker research boost for spinout Empower Therapeutics |
University of B... |
Fri, 01/07/2022 - 13:20 |
Boston Scientific to Present New Data on Advances in Chronic Pain Care at the 2022 North American Neuromodulation Society (NANS) Meeting |
Boston Scientific |
Thu, 12/02/2021 - 06:00 |
No clear answer to whether prescribed opioid use in children leads to later drug misuse: study |
University of A... |
Tue, 11/16/2021 - 02:12 |
FDA Authorizes Marketing of Virtual Reality System for Chronic Pain Reduction |
FDA |
Tue, 11/02/2021 - 02:57 |
Relieving chronic pain with CBT |
Group Health |
Thu, 10/14/2021 - 04:43 |
Antibe Therapeutics Provides Update on Otenaproxesul and Expanded Drug Pipeline |
Antibe Therapeutics |